[1]王伊凡,李思远,张 姣.右美托咪定预处理通过PI3K/Akt/mTOR信号通路对心肌缺血再灌注大鼠心脏损伤和心肌组织自噬的影响[J].陕西医学杂志,2023,52(10):1299-1303.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.004]
　WANG Yifan,LI Siyuan,ZHANG Jiao.Effects of dexmedetomidine preconditioning on cardiac injury and myocardial autophagy in rats with myocardial ischemia-reperfusion through PI3K/Akt/mTOR signaling pathway[J].,2023,52(10):1299-1303.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.004]
点击复制

右美托咪定预处理通过PI3K/Akt/mTOR信号通路对心肌缺血再灌注大鼠心脏损伤和心肌组织自噬的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年10期
页码:
1299-1303
栏目:
基础研究
出版日期:
2023-10-05

文章信息/Info

Title:
Effects of dexmedetomidine preconditioning on cardiac injury and myocardial autophagy in rats with myocardial ischemia-reperfusion through PI3K/Akt/mTOR signaling pathway
作者:
王伊凡1; 2; 李思远1; 3; 张 姣4
(1.西安交通大学第二附属医院麻醉科,陕西 西安 710004; 2.咸阳市第一人民医院麻醉科,陕西 咸阳 712099; 3.西安国际医学中心医院麻醉与舒适化医疗中心,陕西 西安 710100; 4.咸阳市中心医院麻醉科,陕西 咸阳 712099)
Author(s):
WANG Yifan; LI Siyuan; ZHANG Jiao
(Department of Anesthesiology,the Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710004,China)
关键词:
心肌缺血再灌注;  右美托咪定;  预处理;  心脏损伤;  心肌组织自噬;  PI3K/Akt/mTOR信号通路
Keywords:
Myocardial ischemia-reperfusion;  Dextrmetomidine;  Pretreatment;  Heart injury;  Autophagy of myocardial tissue;  PI3K/Akt/mTOR signaling pathway
分类号:
R 542.2
DOI:
DOI:10.3969/j.issn.1000-7377.2023.10.004
文献标志码:
A
摘要:
目的: 探讨右美托咪定预处理通过磷脂酰肌醇3-激酶/蛋白激酶B/雷帕霉素靶蛋白(PI3K/Akt/mTOR)信号通路对心肌缺血再灌注大鼠心脏损伤和心肌组织自噬的影响。方法:60只SD大鼠随机分为假手术组(n=20)、心肌缺血再灌注组(n=20)和右美托咪定预处理组(n=20),建立心肌缺血再灌注损伤模型。假手术组仅接受假手术而不造成心肌缺血,右美托咪定预处理组输注右美托咪定。比较各组大鼠心脏损伤、心肌细胞自噬、PI3K/Akt/mTOR表达、氧化应激及炎症指标。结果:与假手术组比较,右美托咪定预处理组、心肌缺血再灌注组血清肌酸激酶同工酶(CK-MB)、乳酸脱氢酶(LDH)水平依次升高,且右美托咪定预处理组心肌梗死面积百分比明显小于心肌缺血再灌注组(均P<0.05)。与假手术组比较,右美托咪定预处理组、心肌缺血再灌注组心肌组织中LC3、Beclin、P62蛋白表达依次升高(均P<0.05)。与假手术组比较,右美托咪定预处理组、心肌缺血再灌注组心肌组织中PI3K/Akt/mTOR表达依次下降(均P<0.05)。与假手术组比较,右美托咪定预处理组、心肌缺血再灌注组血清髓过氧化物酶(MPO)、丙二醛(MDA)水平依次升高,血清超氧化物歧化酶(SOD)水平依次下降(均P<0.05)。与假手术组比较,右美托咪定预处理组、心肌缺血再灌注组血清白介素-6(IL-6)、白介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)水平依次升高(均P<0.05)。结论:右美托咪定预处理能够保护心肌缺血再灌注损伤大鼠心脏功能,可抑制炎症因子表达、减轻氧化应激反应,其作用机制可能与下调心肌细胞自噬蛋白表达,从而激活PI3K/Akt/mTOR信号通路有关。
Abstract:
Objective:To investigate the effects of dexmedetomidine preconditioning on cardiac injury and myocardial autophagy in rats with myocardial ischemia-reperfusion through the PI3K/Akt/mTOR signal pathway.Methods:Sixty SD rats were randomly divided into sham operation group(n=20),myocardial ischemia reperfusion group(n=20),and dexmedetomidine preconditioning group(n=20)to establish myocardial ischemia reperfusion injury models.The sham operation group received only sham surgery without myocardial ischemia,while the dexmedetomidine preconditioning group received infusion of dexmedetomidine.Cardiac injury,cardiomyocyte autophagy,PI3K/Akt/mTOR expression,oxidative stress,and inflammatory markers were compared in each group.Results:Compared with the sham operation group,the levels of serum creatine kinase isoenzyme(CK-MB)and lactate dehydrogenase(LDH)in the dexmedetomidine preconditioning group and myocardial ischemia reperfusion group increased sequentially,and the percentage of myocardial infarction area in the dexmedetomidine preconditioning group was significantly smaller than that in the myocardial ischemia reperfusion group(all P<0.05).Compared with the sham operation group,the expression of LC3,Beclin,and P62 proteins in myocardial tissue of the dexmedetomidine preconditioning group and the myocardial ischemia reperfusion group increased sequentially(all P<0.05).Compared with the sham operation group,the expression of PI3K/Akt/mTOR in myocardial tissue of the dexmedetomidine preconditioning group and the myocardial ischemia reperfusion group decreased sequentially(all P<0.05).Compared with the sham operation group,the levels of serum myeloperoxidase(MPO)and malondialdehyde(MDA)in the dexmedetomidine preconditioning group and myocardial ischemia reperfusion group increased sequentially,while the levels of serum superoxide dismutase(SOD)decreased sequentially(all P<0.05).Compared with the sham operation group,the serum levels of interleukin-6(IL-6)and IL-1β,tumor necrosis factor-α(TNF-α)in the dexmedetomidine preconditioning group and myocardial ischemia reperfusion group were increased sequentially(all P<0.05).Conclusion:Preconditioning with dexmedetomidine can protect cardiac function in rats with myocardial ischemia-reperfusion injury,inhibit the expression of inflammatory factors,and alleviate oxidative stress reactions.The mechanism of its action may be related to downregulating the expression of autophagic proteins in myocardial cells,thereby activating the PI3K/Akt/mTOR signaling pathway.

参考文献/References:

[1] Gunata M,Parlakpinar H.A review of myocardial ischaemia/reperfusion injury:Pathophysiology,experimental models,biomarkers,genetics and pharmacological treatment[J].Cell Biochem Funct,2021,39(2):190-217.
[2] 王 辉,嵇富海,孟晓文,等.右美托咪定预处理对大鼠心肌缺血/再灌注损伤时心肌组织内质网应激的影响[J].国际麻醉学与复苏杂志,2020,41(8):737-741.
[3] Mokhtari B,Badalzadeh R.The potentials of distinct functions of autophagy to be targeted for attenuation of myocardial ischemia/reperfusion injury in preclinical studies:An up-to-date review[J].J Physiol Biochem,2021,77(3):377-404.
[4] 李晓滨,白建云,赵启兵.右美托咪定对心肌缺血再灌注损伤大鼠的作用及机制研究[J].陕西医学杂志,2022,51(9):1060-1065.
[5] 何妙嬴,张燚格,柳冬冬,等.电针内关预处理对心肌缺血再灌注损伤大鼠心肌PI3K/Akt通路的影响[J].陕西中医,2023,44(3):298-303.
[6] 严斐斐,张 超,王艾丽,等.二甲双胍调控PI3K/Akt通路对心肌缺血再灌注模型大鼠心肌细胞自噬的影响研究[J].中国药师,2019,22(11):1980-1985.
[7] Davidson SM,Ferdinandy P,Andreadou I,et al.Multitarget strategies to reduce myocardial ischemia/reperfusion injury:JACC review topic of the week[J].J Am Coll Cardiol,2019,73(1):89-99.
[8] 秦少博,黄增刚.缬沙坦/氨氯地平通过调控miR-21对心肌缺血/再灌注损伤大鼠的保护作用及机制研究[J].陕西医学杂志,2022,51(4):396-400,405.
[9] 殷存芝,陈 慧,陈玉姣,等.JNK信号通路在右美托咪定预处理减轻大鼠离体心肌缺血再灌注损伤中的作用[J].重庆医学,2021,50(22):3786-3792.
[10] Chen HY,Xiao ZZ,Ling X,et al.ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia/reperfusion injury by regulating autophagy[J].Mol Med,2021,27(1):1-14.
[11] Li H,Zheng F,Zhang Y,et al.Resveratrol,novel application by preconditioning to attenuate myocardial ischemia/reperfusion injury in mice through regulate AMPK pathway and autophagy level[J].J Cell Mol Med,2022,26(15):4216-4229.
[12] 刘 琨,罗兴晶,许鹏程.右美托咪定通过PI3K/Akt通路减弱大鼠离体心脏缺血/再灌注损伤中LC3表达[J].国际麻醉学与复苏杂志,2020,41(11):1070-1075.
[13] Li X,Hu X,Wang J,et al.Inhibition of autophagy via activation of PI3K/Akt/mTOR pathway contributes to the protection of hesperidin against myocardial ischemia/reperfusion injury[J].Int J Mol Med,2018,42(4):1917-1924.
[14] Gao C,Wang R,Li B,et al.TXNIP/Redd1 signalling and excessive autophagy:A novel mechanism of myocardial ischaemia/reperfusion injury in mice[J].Cardiovasc Res,2020,116(3):645-657.
[15] 田俊斌,赵 静,吕建瑞,等.丝裂原活化蛋白激酶/细胞外信号调节激酶信号通路在穿心莲内酯治疗心肌缺血/再灌注损伤大鼠中的分子机制[J].陕西中医,2022,43(5):575-579.
[16] Yovitania V,Fu QH,Pei J,et al.Neuroprotective effect of electroacupuncture against acute ischemic stroke via PI3K-Akt-mTOR pathway-mediated autophagy[J].World J Trad Chinese,2022,8(3):339.
[17] 王松迪.右美托咪定调控PI3K/Akt通路对心肌再灌注大鼠心肌自噬的影响[J].中国医院用药评价与分析,2020,20(6):689-694.
[18] 张晓晓,李树华,杨 华,等.右美托咪定预处理对大鼠心肌缺血再灌注损伤时HMGB1/TLR4/NF-κB信号通路的影响[J].医学综述,2021,27(14):2899-2903.
[19] 付华君,孟 娟,宋文英,等.紫檀芪调节PI3K/Akt/mTOR信号通路保护心肌缺血再灌注损伤大鼠的作用机制研究[J].中西医结合心脑血管病杂志,2022,20(7):1227-1231.
[20] 崔健昆,耿乃志,孟凡吉,等.去甲氧基姜黄素通过PI3K-Akt-mTOR信号通路调控细胞自噬对心肌缺血再灌注损伤大鼠的保护作用研究[J].中医药学报,2020,48(8):19-24.

相似文献/References:

[1]朱 婧,郭建丽.氙气预处理对心肌缺血再灌注损伤大鼠心肌细胞保护作用研究[J].陕西医学杂志,2019,(1):3.
　ZU Jing,GUO Jianli..Protective effect of hernia preconditioning on myocardial cells in rats with myocardial ischemia reperfusion injury[J].,2019,(10):3.
[2]薛璋明,周绍文△,张 娟,等.羟考酮联合右美托咪定应用于区域麻醉镇静临床观察[J].陕西医学杂志,2020,49(2):231.
　XUE Zhangming,ZHOU Shaowen,ZHANG Juan,et al.Clinical observation of sedation under regional anesthesia with oxycodone combined with dexmedetomidine[J].,2020,49(10):231.
[3]杨 昊,郭 聪△.右美托咪定在降低老年腰椎手术患者术后认知功能障碍发生率中的应用[J].陕西医学杂志,2020,49(5):608.
　YANG Hao,GUO Cong..Application of dexmedetomidine in reducing the incidence of postoperative cognitive dysfunction in elderly patients undergoing lumbar surgery[J].,2020,49(10):608.
[4]张 祎,陈 权,尚 游.体温保护联合右美托咪定预防老年脊柱手术患者术后谵妄及寒战临床效果观察[J].陕西医学杂志,2021,50(3):308.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.013]
[5]任学智,田芳玲,李 丹.七氟烷吸入全麻后持续泵入右美托咪定对腹腔镜胆囊切除患者镇痛效果研究[J].陕西医学杂志,2021,50(8):1007.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.026]
[6]郭 聪,杨 昊.罗哌卡因复合不同剂量右美托咪定腹横肌平面阻滞对胃肠道腹腔镜手术患者镇痛及术后认知功能的影响[J].陕西医学杂志,2021,50(8):1011.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.027]
　GUO Cong,YANG Hao.Effect of ropivacaine combined with different doses of dexmedetomidine in transversus abdominis plane block on intraoperative analgesia and the incidence of postoperative cognitive dysfunction in gastrointestinal laparoscopic surgery[J].,2021,50(10):1011.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.027]
[7]单兆亚,王 波.右美托咪定调控急性痛风性关节炎模型大鼠血清炎性因子水平及滑膜功能效果研究[J].陕西医学杂志,2021,50(9):1052.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.003]
　SHAN Zhaoya,WANG Bo.Effect of dexmedetomidine on regulating serum inflammatory factors and synovial function in rats with acute gouty arthritis[J].,2021,50(10):1052.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.003]
[8]王 瑗,冯建梅,卫白杨.右美托咪定对坐骨神经慢性压迫损伤模型大鼠神经病理性疼痛的缓解作用及机制研究[J].陕西医学杂志,2021,50(12):1492.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.006]
　WANG Yuan,FENG Jianmei,WEI Baiyang.Alleviating effect and mechanism of dexmedetomidine on chronic neuropathic pain in rat model with chronic compression injury of sciatic nerve[J].,2021,50(10):1492.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.006]
[9]梁 赟,佘 濛,高子军,等.智能自控静脉镇痛泵用于腰椎后路融合术后患者镇痛效果研究[J].陕西医学杂志,2022,51(2):180.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.012]
　LIANG Yun,SHE Meng,GAO Zijun,et al.Analgesic effect of smart-PCIA on patients after posterior lumbar fusion[J].,2022,51(10):180.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.012]
[10]王兴程,张向宁,侯崇智,等.右美托咪定在脓毒症治疗中的作用及机制研究进展[J].陕西医学杂志,2022,51(3):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
　WANG Xingcheng,ZHANG Xiangning,HOU Chongzhi,et al.Research progress on the role and mechanism of dexmedetomidine in the treatment of sepsis[J].,2022,51(10):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]

备注/Memo

备注/Memo:
基金项目:陕西省卫生健康科研基金资助项目(2018D039)
更新日期/Last Update: 2023-10-07